Diquafosol tetrasodium clinical trials
How each study uses diquafosol tetrasodium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the diquafosol tetrasodium studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2023 (4)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2005 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 7
He Eye Hospital (6) · Merck Sharp & Dohme LLC (5) · Santen Pharmaceutical Co., Ltd. (2) · Indonesia University (1)
Studies
Open first, then newest update. How each study uses diquafosol tetrasodium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry EyeNot yet recruitingNot applicableHe Eye HospitalNCT06537349Written as 3% Diquafosol tetrasodiumHow we know
- Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in IndonesiaRecruitingPhase 2Indonesia UniversityNCT06146881Written as Diquafosol sodium 3%How we know
- Diquafosol vs Hyaluronic Acid for Diabetic Dry EyeCompletedNot applicableHe Eye HospitalNCT05682547Written as 3% Diquafosol tetrasodiumHow we know
- Management of DE With IPL in Combination With DQSCompletedNot applicableHe Eye HospitalNCT05694026Written as Diquafosol tetrasodiumHow we know
- Temperature on Evaporative Dry EyeStatus unknownNot applicableHe Eye HospitalNCT05720754Written as Diquafosol tetrasodiumHow we know
- Diquafosol Ophthalmic Solution for Dry Eye SymptomsStatus unknownNot applicableHe Eye HospitalNCT04980144Written as 3% Diquafosol tetrasodiumHow we know
- Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry EyeStatus unknownNot applicableHe Eye HospitalNCT05193331Written as 3% Diquafosol tetrasodiumHow we know
- Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedPhase 3Merck Sharp & Dohme LLCNCT00404131Written as diquafosol tetrasodium (INS365) Ophthalmic SolutionHow we know
- Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedPhase 3Merck Sharp & Dohme LLCNCT00403715Written as diquafosol tetrasodium (INS365) Ophthalmic SolutionHow we know
- A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)TerminatedPhase 2Merck Sharp & Dohme LLCNCT01381731Written as diquafosol tetrasodium ophthalmic solution 2%How we know
- A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye DiseaseCompletedPhase 2Merck Sharp & Dohme LLCNCT00679718Written as diquafosol tetrasodium (INS365) ophthalmic solutionHow we know
- A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic SolutionCompletedPhase 2Merck Sharp & Dohme LLCNCT00680108Written as diquafosol tetrasodium (INS365) ophthalmic solutionHow we know
- Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedPhase 3Santen Pharmaceutical Co., Ltd.NCT01240382Written as 3% DE-089 ophthalmic solutionHow we know
- Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedPhase 2Santen Pharmaceutical Co., Ltd.NCT01189032Written as DE-089 ophthalmic solutionHow we know
As the comparator · 1 — what is tested is compared with diquafosol tetrasodium
Codes
What other systems call diquafosol tetrasodium · ClinicalTrials.gg INT018447
- UNII (FDA) X8T9SBH9LLDIQUAFOSOL TETRASODIUMConfirmed FDA, Wikidata
- Wikidata Q27293698diquafosol tetrasodiumConfirmed FDA, Wikidata
- NCI Thesaurus C65437Diquafosol TetrasodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | X8T9SBH9LL | DIQUAFOSOL TETRASODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q27293698 | diquafosol tetrasodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C65437 | Diquafosol Tetrasodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.